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An important class of cytolytic antimicrobial peptides (AMPs) assumes an amphipathic, α-helical conformation that permits efficient
interaction with biological membranes. Host defence peptides of this type are widespread in nature, and numerous synthetic model AMPs have
been derived from these or designed de novo based on their characteristics. In this review we provide an overview of the ‘sequence template’
approach which we have used to design potent artificial helical AMPs, to guide structure–activity relationship studies aimed at their optimization,
and to help identify novel natural AMP sequences. Combining this approach with the rational use of natural and non-proteinogenic amino acid
building blocks has allowed us to probe the individual effects on the peptides' activity of structural and physico-chemical parameters such as the
size, propensity for helical structuring, amphipathic hydrophobicity, cationicity, and hydrophobic or polar sector characteristics. These studies
furthermore provided useful insights into alternative modes of action for natural membrane-active helical peptides.
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The interactions of peptides with membranes are essential to
many processes of physiological or pathological relevance, such
as the effects of hormones, toxins and the host defence peptides
(HDPs) of innate immunity [1–3]. Understanding the mode of
action of such peptides can help to improve design strategies for
the development of therapeutic agents, ranging from immuno-
toxins and antitumour drugs to anti-infective agents capable of
overcoming the currently serious problem of resistance to
conventional antibiotics [4–6]. The activity of many antimi-
crobial peptides (AMPs) depends principally on membrane
permeabilization or lysis, and several mechanisms of action
have been proposed, ranging from the formation of highly
organized transmembrane pores, to that of the more dynamic
supramolecular peptide/lipid complexes leading to toroidal
pores, or to membrane damage via a relatively disorganized,
detergent-like disaggregation due to hydrophobic and/or
electrostatic interactions with the membrane surface [7–11].
However, the molecular details underlying these processes,
which have important implications for the selectivity of the
peptides' membranolytic action, are only just starting to be
understood.
One important class of membrane-interacting AMPs
assumes an amphipathic, α-helical conformation that permits
insertion of a well defined hydrophobic sector into the lipid
bilayer [8]. They represent one of the most successful designs
in nature, being produced by all types of organisms from
bacteria to mammals, and they are very numerous (see the
antimicrobial sequence database AMSDb at http://www.bbcm.
units.it/~tossi/antimic.html). Unlike other types of AMPs,
such as disulphide-containing defensins and bacteriocins, this
type of small linear peptides are relatively easy to synthesize
chemically, and their structuring can be followed by simple
spectroscopic techniques, so their mode of action has been
most extensively studied. Data generated by different studies
is however sometimes conflicting. This is partly due to the
fact that biophysical studies and antimicrobial activity assays
have been performed by different groups under quite different
conditions, and partly because several different physico-
chemical attributes interact quite subtly to modulate the
peptides' activities.
In this review, we describe an approach for designing helical
AMPs that is based on the identification of common sequence
patterns in numerous natural host defence peptides. We have
used this approach to design several series of peptides in which
we have rationally and independently varied single structural or
physico-chemical parameters, and have then used standardized
assay conditions to determine their antimicrobial and membra-nolytic activities, thus allowing for firmer conclusions on their
mode of action.
2. Structure–activity relationship studies on model AMPs
2.1. Methods used to design and characterize AMPs
SAR studies on α-helical antimicrobial peptides have mainly
involved the systematic modification of naturally occurring
HDPs or the de novo design of simple model antimicrobial
peptides (AMPs) predicted to form amphipathic α-helices [8].
The ultimate aim for most of these studies was to obtain
molecules with increased antimicrobial activity accompanied by
decreased toxicity toward host cells, in view of potential
therapeutic applications. Structuring of the peptides was most
often studied by CD spectroscopy in the presence of
trifluoroethanol (TFE) or SDS micelles [12], or by CD, NMR
or attenuated total reflection FTIR in the presence of
phospholipid vesicles [13–16]. Antimicrobial activity was
generally defined in vitro as the minimum inhibitory concen-
tration (MIC), using either microbroth serial dilution or radial
diffusion assays. These were sometimes supplemented by
microbial killing and/or membrane permeabilization kinetics
studies [17,18]. Alternatively, several biophysical methods have
been used to probe the interactions of AMPs with model
phospholipid membranes [9,19–25]. Host toxicity has generally
been evaluated simply as haemolytic activity, although the
susceptibility of erythrocytes to these AMPs is not necessarily
extendable to other host cells, and can vary markedly with
erythrocytes from different mammalian species.
2.1.1. Four general approaches have been used to design new
AMPs and guide SAR studies [8]
2.1.1.1. Sequence modification. Naturally occurring helical
HDPs were modified by deleting, adding, or replacing one or
more residues, or by truncating the peptides at the N- or C-
termini, or by assembling chimeric peptides from segments of
different natural peptides. This type of modification has been
extensively applied to study insect cecropins, magainin and
other frog peptides, bee venom melittin and mammalian
cathelicidins in particular [8,26–29].
2.1.1.2. Minimalist approaches. AMPs are designed de novo
based purely on the requirement for an amphipathic α-helical
structure, limiting the types of residues used to one or the other
of the basic amino acids lysine or arginine, and one or two of the
hydrophobic residues alanine, leucine/isoleucine, phenylala-
nine, or tryptophan. This can result in potent antimicrobial
1438 I. Zelezetsky, A. Tossi / Biochimica et Biophysica Acta 1758 (2006) 1436–1449agents, but ignores sequence attributes selected for by
evolution, which can lead to increased cytotoxicity.
2.1.1.3. Combinatorial libraries. Synthetic or biological
combinatorial libraries are powerful tools for rapidly obtaining
optimized classes of active compounds. Regarding chemical
synthesis methods, the size of α-helical AMPs (generally over
12–15 residues) makes positional scanning or iterative
approaches unpractical, unless the variance implicit in the
combinatorial approach is reduced. This can be accomplished
by limiting the number of amino acid types used to construct theFig. 1. Sequence template and information derived from the analysis of residue distri
starting from the N-terminus. (A) Positional frequency of residue types plotted on a h
Hfl, respectively, indicate a preference for hydrophobic or hydrophilic residues [furth
residue type predominates. The types of residues considered for each position in pepti
proteinogenic Nle, Nva or Abu, αaa indicates α-branched Aib, Acp, Deg or Dpg, O
amino acids are D-isomers. (C–E) Range and frequency, in naturally occurring α-he
and (E) the relative amphipathicity. The first two parameters were determined for thlibrary (converging with the minimalist approach), or by
scanning only certain positions in natural peptides (converging
with the sequence modification methods) [30,31]. Biological
libraries can make use of the phage-display technology [32], or
of methods such as the “Suicide Expression System” (SES),
which involves directed mutation of AMP genes transfected
into bacterial expression systems [33].
2.1.1.4. The template-assisted approach. Sequence templates
can be obtained by comparing structurally homologous
stretches from a large collection of naturally occurring HDPsbution in the N-terminal stretch of α-helical AMPs from natural sources, aligned
elical wheel diagram; (B) Sequence template derived from this analysis: Hfb and
er defined as cationic (+), anionic (−) or neutral polar (0)]; Xaa indicates that no
de construction are indicated below the template. Zaa indicates hydrophobic non-
aa indicates hydrophilic non-proteinogenic Orn, Dab, Dap or Hse, underlined
lical AMPs, of (C) the net cationicity; (D) the hydrophobic residue composition
e full sequences, while the latter for the 20 residue N-terminal helical stretch.
Table 1
Residue and property variations
Residue variation Property variation Effect
Orn→Gln→Glu cationic→neutral→anionic cationicity
Orn/Gln→Nle;
Nle→Orn
scrambled peptides amphipathicity
Nle→Nva→Abu→Ala linear aliphatic
side-chain size
hydrophobic
sector
Lys→Orn→Dab→Dap cationic residue side-chain size polar sector
Gln→Asn→Hse→Ser neutral polar residue
side-chain size
polar sector
Nle→α-branched
aliphatic
helix stabilizing residues stability of
helix
Orn→D-Orn/Pro;
Nle→D-Nle/Pro
helix destabilizing residues stability of
helix
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charged, polar, hydrophobic, etc.) [8,34,35]. These can then be
used to design AMPs de novo. The rationale is not to determine
significant sequence homologies or the positional conservation
of specific amino acids (which is in any case poor α-helical
AMPs [8]) but rather to identify underlying patterns in the
distribution of different types of residues, and in the variation of
physico-chemical parameters, which may be correlated to
potency and specificity. Using the template as a guide
significantly reduces the number of variants that need to be
synthesized in order to obtain useful results, with respect to the
conventional “sequence modification” approach, while main-
taining evolutionarily conserved sequence patterns that are lost
in the “minimalist” approach. Furthermore, this approach can
help guide both synthetic and biological library construction.
In the following sections we provide a detailed overview of
how the template-assisted approach has been used to both
design or identify novel peptides with a broad-spectrum
antimicrobial activity, and to probe the structural factors that
influence their antimicrobial potency and selectivity.
2.2. Parameters influencing AMP activity
The type of AMP we are considering in this review assumes
an amphipathic, helical structure in the presence of microbial
membranes, in which polar/charged residues are segregated on
one side of the helix (the polar sector) and hydrophobic residues
are segregated on the other side (the hydrophobic sector). The
peptides can then interact with the membrane by inserting the
hydrophobic sector into the lipid bilayer, subsequently leading
to fatal lesions. Several structural and physico-chemical
parameters can influence their potency and spectrum of activity.
These include i) the size; ii) residue arrangement; iii) the
propensity for helical structuring; iv) the charge (cationicity); v)
the global hydrophobicity; vi) the amphipathicity; vii) the angle
subtended by each sector on a wheel projection and viii) the
sector depths, which are determined by the size of side-chains in
the residues that form them [8,36,37]. These parameters are
intimately related, so that modifications aimed at altering one
can result in significant changes to one or more of the others.
Understanding and controlling these interrelationships is the
key to designing novel peptides with increased potency and
more directed activity. The comparative analysis of natural HDP
sequences, apart from allowing the definition of conserved
residue patterns or features that are important for activity and
which can be incorporated into the design of novel AMPs, can
also help to define critical value ranges for some of these
parameters (see Fig. 1C–E).
Our laboratory originally developed and used the sequence
template concept to guide the design of potent, broad-spectrum
AMPs [34,35]. Subsequently it was used to guide rational
sequence modifications that resulted in the systematic variation
of the abovementioned parameters, independently from each
other, so as to test their individual role in modulating the
potency and selectivity [8,38–40]. The approach could also be
used to guide database searches so as to identify novel potential
antimicrobial peptides [41]. Finally, the possibility of generat-ing simplified model peptides with defined structural and
physico-chemical characteristics was quite useful in explaining
the behaviour of natural HDPs, and how this changes with their
evolution in different species [42].
There follows an overview of our analyses of the structural
and physico-chemical characteristics of α-helical AMPs and of
the SAR studies that have been carried out to determine the
relevance of the different parameters that define the potency and
selectivity of AMPs.
3. Sequence analyses
The sequences of over 150 natural antimicrobial peptides,
ranging from 16 to 44 amino acid residues in length, produced
by several vertebrate and invertebrate animal species, were
compared and analyzed [8,34]. Despite a considerable variation
in their architecture, all these peptides present an N-terminal α-
helical domain that is essential, and often sufficient, for
antimicrobial activity [27,28,43,44]. Given the wide range in
peptide size, the analysis was thus limited to the first 20 residues
in each sequence, ensuring that the N-terminal domain was
adequately covered, resulting in a template which is a
reasonable basis for the design of short helical AMPs. In any
large series of aligned sequences, a random distribution of
amino acids at any position would result in roughly a 5%
frequency for each type of amino acid. A frequency
significantly above or below this value thus indicates a
preference or antipathy at that position for any given amino
acid, which may have been selected for by evolution, and thus
be related to the peptide's function.
Positional residue conservation in the aligned AMP
sequence stretches was in fact found to be relatively poor,
excepting positions 1 (>70% Gly) and 8 (>50% Lys). A defi-
nite pattern however emerged when considering the posi-
tional conservation of residue types (Fig. 1A). The resulting
sequence template (Fig. 1B) defines the sequence pattern for
a typical α-helical AMP, in terms of charged, neutral polar
or hydrophobic residues, while allowing a considerable free-
dom in the individual amino acids that can be used to
construct the peptide, and consequently on properties such as
cationicity, mean hydrophobicity and amphipathicity. An
analysis of how these parameters vary among the natural
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natural peptides have a net charge ranging from +4 to +9, a 40–
60% content of hydrophobic residues (corresponding to a
hydrophobic sector that subtends from 140° to 200° on a helical
wheel projection) and a relative amphipathicity ranging 50–
60% optimal.
To carry out these analyses we have developed a consensus
hydrophobicity scale ad hoc, which includes non-proteinogenic
amino acids [45] and appropriate analysis software (http://www.
bbcm.units.it/∼tossi/antimic.html), allowing quantitative esti-
mates of per residue hydrophobicity and amphipathicity. We
prefer to express the latter parameter as relative to its maximum
possible value in an 18 residue, perfectly amphipathic peptide toFig. 2. Helical wheel projection of some selected peptides. Residue side-chain struc
oxygen and black for nitrogen). The hydrophobic face is shaded, while the depth offacilitate comparison. Helix structuring propensity is instead
estimated by comparing the molar ellipticity of peptides at
222 nm in phosphate buffer and in the presence of helix
favouring trifluoroethanol (50%) and/or SDS micelles (10 mM).
4. Peptide design using the sequence template
Over 50 different synthetic α-helical AMPs have been
designed by filling the sequence template with proteinogenic or
non-proteinogenic residues whose side-chain characteristics
were rationally selected to systematically and independently
vary the helix forming propensity, the cationicity, the
amphipathicity, the global hydrophobicity and the hydrophobictures are shown schematically with atoms as circles (white for carbon, grey for
the polar sector is indicatively shown by a dotted frame.
Table 2
Effect of parameter variations on antimicrobial activity
Peptide Charge % Helicity Property Microorganism a Haemolysis
(50% TFE) EC PA ST SA
MIC
BM
(μM)
CA CN AN (%) 10
μM peptide
P19(6) +6 50 directly derived
from template
0.5 1 1 2 0.5 16 2 >32 7
P19(6|E) +6 50 directly derived
from template
1 1 1 4 2 4 2 >32 10
P19(1|E) +1 55 very low
cationicity
>32 >32 >32 >32 >32 >32 >32 >32 0
P19(3|E) +3 60 low cationicity 2 16 4 16 2 >32 8 >32 <5
P19(8) +8 40 high cationicity 1 1 2–4 16 2 2–4 2 >32 <5
P19(9|B) +9 60 high cationicity,
increased
structuring
0.5–1 1 1 2 0.5–1 1 1 16 30
D-P19(9|B) +9 60 all-D peptide,
left handed helix
0.5 1 0.5–1 1 0.5 1–2 1 16 15
P19(6|P) +6 25 destabilized structure 2–4 2 32 >32 16 >32 32 >32 <5
P19(6|D) +6 <5 destabilized structure 2 2 16 >32 16 >32 16 >32 <5
P19(8|P) +8 <5 high cationicity,
destabilized structure
8 8 >32 >32 32 >32 16 >32 5
P19(6|s) +6 35 scrambled peptide,
low amphipathicity
4–8 4–8 32 32 8 >32 8–16 >32 <7
P19(5|Acp) +5 100 (60) b highly stable
structure
8 (0.5) 1 6
(0.5)
16 (1) 4 –
8 (1)
4
(0.5)
4 – >95
P19(5) +5 60 directly derived
from template
1 1 2 4 1–2 8 4 >32 10±5
P19(5|B) +5 75 stabilized, deep
hydrophobic sector
1 2 1 2–4 1 8 4 >32 10±5
P19(5|Dpg) +5 35 dense hydrophobic
sector
2 2 4 2 4 >32 – >32 25
P19(5|Deg) +5 60 decreased
hydrophobic
sector depth
16 >32 >32 >32 >32 >32 – – <5
P19(5|Abu) +5 40 shallow hydrophobic
sector
>32 >32 >32 >32 >32 >32 >32 >32 <5
P19(5|Gln–Lys) +5 90 very deep polar
sector
1 0.5 1–2 1 1 16 – >32 25±5
P19(5|Gln–Orn) +5 75 deep polar sector 1 2 1 2–4 1 8 – >32 10±5
P19(5|Hse–Dab) +5 90 shallow polar sector 1 1 2 1 1 16 – >32 25±5
P19(5|Ser–Dap) +5 90 very shallow polar
sector
2 4 16 4 4 >32 – >32 15±10
P19(9|B,Gly7) +9 70 flexible AA at
position 7
1 0.5 2 2 1 – – – 15
P19(9|B,Pro7) +9 40 helix-breaking AA
at position 7
1 1 4 32 2 – – – 5
P19(9|Ala7) +9 75 proteinogenic
version of P19(9|B)
1 1 2 4 1 – – – 15
P19(9|Gly7) +9 90 flexible AA at
position 7
0.5 0.5 2 2 2 – – – 10
P19(9|Gly7,14) +9 70 flexible AA at
positions 7 and 14
4 16 >32 ≥32 >32 – – – 5
P19(9|Gly14) +9 60 flexible AA at
position 14
4 8 ≥32 >32 32 – – – 10
Pilosulin P2 +7 40 high similarity to
sequence template
1 4 4–8 4–8 2 – – – 15
a EC, Escherichia coli (ML-35); PA, Pseudomonas aeruginosa (ATCC 27853); ST, Salmonella typhimurium (ATCC 14028); SA, Staphylococcus aureus (710A);
BM, Bacillus megaterium (BM11); CA, Candida albicans (clinical isolate); CN, Cryptococcus neoformans (clinical isolate); AN, Aspergillus niger (clinical isolate).
b % helicity in aqueous solution is in parentheses.
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generally fixed the size of the AMPs to 19 residues, which is
amply sufficient for activity, including a C-terminal tyrosine to
aid more accurate quantification. Peptide nomenclature P19(x|N) reflects this length, provides the charge (x) and indicates key
features or residues used in peptide construction (N).
The types of residues contemplated for each position are
indicated below the template in Fig. 1B, and the types of
1442 I. Zelezetsky, A. Tossi / Biochimica et Biophysica Acta 1758 (2006) 1436–1449modifications that were effected are summarized in Table 1.
Interchanging Orn, Glu and Gln residues in positions defined as
hydrophilic allowed to vary the cationicity from +1 to +9
without markedly affecting other parameters, as these residues
have a similar size and hydrophobicity index. Interchanging
them with the aliphatic residue Nle, of the same size, allowed to
modulate only amphipathicity. Interchanging alanine, amino-
butyric acid (Abu), norvaline (Nva) and norleucine (Nle)
residues in positions defined as hydrophobic allowed the
variation of linear aliphatic side-chain lengths from one to four
carbon atoms, affecting the depth and hydrophobicity of the
hydrophobic sector. Similarly, interchanging lysine, ornithine
(Orn), diaminobutyric acid (Dab) and diaminopropionic acid
(Dap), or glutamine, asparagine, homoserine (Hse) and serine
residues in positions defined as hydrophilic allowed the
variation of linear cationic or neutral polar side-chain lengths,
affecting the depth of the polar sector. The small branched 2-
aminoisobutyric acid (Aib) and cyclic side-chain aminocyclo-
pentanecarboxylic acid (Acp) were used to stabilize the helical
conformation [46]. Conversely, proline or D-enantiomers of
ornithine and norleucine were used to destabilize the helix.
Some examples of peptides designed using these criteria are
furnished in Fig. 2, which shows a schematic representation of
residue side-chains.
In this manner, the designed peptides were based on a
scaffold which reflects structural elements selected for by
evolution in many different organisms, while the precise
sequence has been rationally adapted to probe the functional
role of specific aspects of the molecules' shape, physical
properties and conformational stability. Peptides directly
derived from the template with charge +5 and +6 [see P19(5),
P19(6), and P19(6|E) in Fig. 2 and Table 2] were found to
assume a well defined helical conformation in 50% trifluor-
oethanol or 10 mM SDS, and to have quite a potent and broad-
range antimicrobial activity, including multi-drug resistant
pathogenic bacterial strains and some yeasts, confirming the
validity of our method [38]. Some bacterial species were not
susceptible (e.g. B. cepacia, P. mirabilis), but these are known to
be intrinsically resistant to the action of AMPs in general.
5. Role of charge (cationicity) in modulating activity of
model peptides
Based on the lead sequences directly obtained from the
template, a set of peptides was designed to probe the effect of
overall cationicity (Table 2). This parameter is clearly
important, as the initial interaction of AMPs with the anionic
microbial surface is generally considered to be an electrostatic
one. Decreasing the charge to +3 or less considerably reduced
potency, and as these peptides had similar mean hydrophobi-
cities, relative amphipathicities and helix forming propensities
to the parent peptides, this activity variation depended solely on
altering the charge. Conversely, increasing the charge up to +9
resulted in a gradual increase in activity. In this case, however,
the higher charge density of the polar sector started to affect the
propensity for helix formation at charge +8, which is reflected in
a reduced spectrum of activity [38]. Introduction of Aib in keyhydrophobic positions to stabilize the structure overcame this
problem and resulted in peptides (e.g. P19(9|B), see Fig. 2)
which, despite a charge of +9, showed a potent activity towards
most tested bacteria, yeasts and fungi. In general, it also resulted
in an increased ability to lyse erythrocytes.
The effect of charge on activity was confirmed by the
addition of charged residues to the N-terminus of selected
peptides. When two ornithine residues were added to an inactive
peptide of charge +1, it led to an increased potency and
spectrum of activity analogous to that of a +3 charged 19-mer,
and similarly for the +3 charged peptide with respect to the one
with charge +5. Conversely, addition of two glutamic acid
residues to the +5 charged peptide resulted in a reduction of
potency and spectrum of activity to levels similar to those of the
+3 charged 19-mer. This indicates that activity depends on the
overall cationicity and not necessarily on the positioning of
basic residues throughout the helical domain. Taking the charge
to +11 did not further improve activity with respect to parent
peptides with charge of +9, indicating that this may be an
optimal maximum charge.
6. Roles of amphipathicity and global hydrophobicity in
determining activity
An amphipathic residue arrangement is amply recognized as
being important for the activity of α-helical AMPs [47–49]. The
ability to structure as an α-helix, without this arrangement, is
not sufficient to provide a potent, broad-range antimicrobial
activity, as demonstrated by a scrambled peptide [see (P19(6|s)
in Table 2, Fig. 2]. This peptide has an identical residue
composition, charge and hydrophobicity and similar helix
forming propensity in 50% TFE as the lead peptide [P19(6|E)],
but its spectrum of activity was effectively restricted to a two
tested Gram-negative species (E. coli ML-35 and P. aeruginosa
ATCC 27853, see Table 2). It does not structure as a helix in the
presence of SDS micelles (Table 2), indicating that either it
cannot interact strongly with a lipid environment or does so by
assuming a non-helical conformation.
A series of peptides was designed with a constant charge and
amphipathic residue arrangement, but a mean hydrophobicity
which varied significantly due to different contents of Nle, Aib
or Abu residues, having aliphatic side-chains of different length
and hydrophobicity. While a moderate decrease in hydropho-
bicity was well tolerated with little variation in MIC values, the
absence of large aliphatic residues completely abolished
biological activity [compare P19(5) with P19(5|B) and P19(5|
Abu), Fig. 2, Table 2] [38,39]. The shallow hydrophobic sector
may be unable to insert sufficiently into biological membranes
so as to kill microorganisms.
7. Propensity for helical structuring modulates both
antimicrobial and cytotoxic activities
Helical structuring is required for AMPs to assume an
amphipathic structure presenting a well defined hydrophobic
sector for membrane insertion. Stabilizing the helical confor-
mation of peptides should thus aid antimicrobial potency.
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that already had a good propensity for helix formation appeared
to have a relatively moderate effect on antimicrobial potency, at
least in terms of the MIC values [compare P19(5) and P19(5|B)
in Table 2]. Conversely, reducing the propensity for helix
formation, by introducing proline residues at key position
(Table 2), considerably decreased potency and effectively
narrowed the activity spectrum to a subset of the Gram-
negative species tested, in line with similar studies carried out
on natural AMPs [27]. A similar effect was also observed after
introduction of six D-amino acid replacements, which also
inhibit helix formation [50] without in any way affecting other
properties such as hydrophobicity.
We have come to the conclusion that the propensity for helix
formation affects the cytotoxicity of peptides towards host cells
more than antimicrobial activity. Our results are in agreement
with those of Shai and coworkers [51], who found that
destructured diastereomeric peptides can have selectively useful
antimicrobial activities with drastically reduced cytotoxicity.
Even without introducing D-amino acids, we found that peptides
such as P19(8), that are less prone to structure due to an
excessive charge density in the polar sector, maintain a
moderate antimicrobial activity with a significantly decreased
toxicity [52]. Stabilizing the structure by introducing Aib
residues as in P19(9|B) resulted in a considerably more potent
but also more cytotoxic peptide. Curiously, its all-D enantiomer,
which forms a left-handed helix that is otherwise identical in
physico-chemical properties, had an entirely analogous spec-
trum of antimicrobial activity as the all-L peptide (see Table 2),
but a significantly lower cytotoxicity [52]. The reason for this
remains unexplained.
We have been able to design a peptide, P19(5|Acp) (see Fig.
2), in which the presence of this α-branched residue stabilized
the helical conformation to the extent that it was already
significantly structured in aqueous solution, in the absence of
membranes or SDS. This peptide was extremely cytotoxic,
confirming the role of helical structuring in modulating this
effect, although it seemed to act via a different mechanism on
host cells than peptides such as P19(9|B), that only structure in
an anisotropic environment (see below).
8. The role of hydrophobic and polar sector depths in
modulating membrane interaction and activity
Helical structuring and hydrophobic face properties, and
their respective roles in determining membrane interaction, are
intimately related. Helix formation permits an optimal spatial
arrangement (sector formation) of aliphatic side-chains for
membrane insertion. The interaction of these side-chains with
the lipid layer in turn stabilizes the helical conformation,
promoting intra-chain H-bonding and reducing main-chain
hydrophobicity, thus allowing a deeper insertion of the whole
molecule into the bilayer. To probe this interrelationship, a set of
peptides was designed in which the depth of the hydrophobic
face was systematically varied, while keeping the polar sector
fixed, by reducing aliphatic side-chain size stepwise from 4 to 1
carbon atoms [39]. In a second set, a longitudinal hydropho-bicity gradient was introduced by systematically decreasing
aliphatic residue side-chain sizes along the helical axis, in either
the N- to C- or the C- to N-terminal directions. In a third set, the
length of side-chains for residues in the polar sector was varied
while keeping the hydrophobic sector constant, to determine
how this affected the activity of peptides insertion via the so
called ‘snorkel’ effect [53]. This proposes that the depth to
which the main-chain sinks into the lipid bilayer is determined
by the length of polar residue side-chains facing away from it,
considering that these are really aliphatic chains with a polar
head.
In all these peptides, other parameters such as size, charge,
polar/hydrophobic residue ratio and angle subtended by
hydrophobic and polar sectors [54,55], were kept constant.
The propensity of the peptides to assume a helical structure in
the presence of SDS micelles depended markedly on the depth
of the hydrophobic sector. A shallow hydrophobic face
correlated with a reduced helix forming propensity and this
was also the case for the peptides with a depth gradient, i.e.
where one or other of the extremities was shallow. This suggests
that the entire hydrophobic sector needs to interact with the lipid
layer in order to stabilize helical structuring.
A clear correlation was observed between RP-HPLC
retention times and both the hydrophobic and polar face depths.
As the C18 layer is a simple model for the membrane lipid
environment [56], this confirms the importance of hydrophobic
interactions in mediating insertion into lipid layer, and also that
a deeper penetration of the molecule into this layer is in fact
allowed by the snorkel effect.
The structural variations described above had a marked
effect on the in vitro antimicrobial potency, in terms of MIC. A
homogeneously shallow hydrophobic face (aliphatic side-
chains of 2 carbon atoms or less) effectively knocked out
activity against all tested microbial strains (Table 2). The
presence of a depth gradient, where only one end of this face is
shallow, also considerably reduced potency and restricted the
spectrum of activity [39]. A limited number of short aliphatic
side-chain residues (3 out of 8) was instead well tolerated, as
long as these were spread throughout the length of the helix, and
especially if they served to stabilize the helical structure. Polar
sector characteristics also had a discernible, albeit less marked,
effect on the antimicrobial potency, supporting a role for the
snorkel effect in the microbial inactivation mechanism.
Furthermore, low MIC values correlated with faster killing
kinetics (indicating a bactericidal effect) and an increased
capacity to permeabilize the cytoplasmic membranes of selected
microorganisms, as monitored via the o-nitrophenyl-β-D-
galactopyranoside colorimetric assay [39]. This is good
evidence that the microbial membrane is a principal target in
the killing action of the peptides.
9. Cytotoxicity on host cells
A simple indication of the selectivity of AMPs for microbial
cells is furnished by their haemolytic activity (Table 2). For our
model peptides it follows a similar trend as the antimicrobial
activity, consistent with a membranolytic mechanism on both
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10 μM, a concentration well above the MIC values of the more
potent peptides. Erythrocyte membrane disruption is affected by
both the hydrophobic face depth and the snorkel effect, and the
presence of an oblique hydrophobicity gradient also seems to
favour haemolytic activity, in contrast with the antimicrobial
activity [39]. Haemolysis is clearly correlated with the
conformational stability [as measured by the degree of helical
structuring in TFE, compare P19(8) and P19(9|B) in Table 2, for
example].
Excessive stabilization of the helix can in fact be doubly
counterproductive. The exceptional conformational stability of
P19(5|Acp), due to the presence of Acp residues, made it
extremely cytotoxic, whereas its antimicrobial potency was
disappointing. Structuring in bulk solution promotes aggrega-
tion and interaction with other molecules in its environment that
can segregate it, so that the antimicrobial activity is markedly
dependent on medium conditions. Other workers have also
observed a correlation between an increased ability to self-
associate in solution, a weaker antimicrobial activity and a
stronger haemolytic activity [15,48].
Cytotoxicity was probed by monitoring the permeabilization
of mouse lymphocytes to propidium iodide, via flow cytometry
(Fig. 3) [39,52]. In the absence of peptides, a homogeneous
population of non-fluorescing, undamaged cells dominates. In
the presence of AMPs a second population of damaged and
propidium iodide permeable cells (high fluorescence, decreased
forward scattering) appears, whose intensity depends both on
the peptides' physico-chemical properties and concentration
[compare P19(8), P19(5) and P19(5|Gln–Lys) in Fig. 3]. SEM
scans of lymphocytes treated under the same conditions indicate
a likely necrotic inactivation of cells via this membrane damage
[52]. The correlation between the degree of helical structuring inFig. 3. Three-dimensional flow cytometric contour-plot analysis of mouse lymphocy
an indicator of size and SS (90° scattering, SSLOG, x-axis) is an indicator of granular
10 μM peptide in PBS (except P19(8) which is 16 μM).TFE and membrane permeabilization was thus confirmed, but
in addition we found that P19(5|Acp), which has a stable helical
conformation already in bulk solution, seemed to act via a
different mechanism. Massive permeabilization to propidium
iodide was accompanied by increased side scatter rather than
forward scatter as with the other peptides, indicating a more
granular morphology, which was confirmed by SEM [39]. As
the potent haemolytic activity of this peptide was reminiscent of
that of the α-helical bee venom toxin melittin, this was also
tested under the same conditions (Fig. 3), with an intermediate
result, both decreased-FS and increased-SS populations being
observed in this case.
10. Different functional types of α-helical AMPs
Our observations suggest two distinct types of helical AMPs
with different modes of action. The first, which we term
“canonical” helical AMPs, has a moderate propensity for helix
formation that derives from their amphipathic residue arrange-
ment, and only structures at the membrane surface, being
present in a free, unstructured form (F-form) in bulk solution
(see Fig. 4). These AMPs tend to be bacteria selective and
generally display a salt and medium independent antimicrobial
activity. Interaction with, and insertion into the membrane (M-
form) requires an adequate balance of cationicity and
amphipathic hydrophobicity in particular, and depends on
both hydrophobic and polar sector depths (‘snorkel’ effect). The
second type of AMP is conformationally stabilized in some
manner (e.g. by the presence of specific residues such as Acp,
covalent bridges in the polar sector [57], or of salt-bridging pairs
of basic and acidic residues in the polar sector, such as in LL-37
[58]). These peptides display a salt-dependent structuring in
bulk solution and are aggregation-prone to mask the so-formedtes treated with selected model peptides and the bee toxin melittin. FS (y-axis) is
ity. The z-axis represents the cellular population intensity. Cells were exposed to
Fig. 4. Schematic representation of alternative structural forms for α-helical AMPs. Most peptides are unstructured in bulk solution (free or F-form). Some peptides are
in salt-dependent equilibrium between the F-form and a structured, aggregated form (A-form). These peptides also tend to bind avidly to medium components, which
segregate them and reduce activity (S-form). Both types of peptides interact with, and insert into biological membranes surface (M-form). The depth of insertion then
depends on the characteristics of the hydrophobic sector and of the polar sector (snorkel effect). The subsequent inactivation mechanisms can then involve formation of
toriodal pores, aggregate channels or micellization via a detergent-like effect. It could also involve translocation of peptides to the cytoplasmic side of the membrane,
and/or their interaction with wall-associated enzymes (secondary effects).
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strongly with other molecules in their environment, which
segregate them (S-form), so that their antimicrobial activities
are highly dependent on medium conditions. This type of AMP
appears to have a different mechanism of interaction with host
cells than the canonical type AMPs, increasing their cytotoxi-
city, whereas it is not yet clear if they interact differently with
bacterial membranes.
In this respect, the behaviour of our model peptides
belonging to the two groups can be used to interpret the
behaviour of natural peptides. For example, peptides like P19(5)
and its variants can be considered to be simplified analogues of
canonical α-helical AMPs such as the much studied amphibian
magainin [2,7,9,21,59], which has similar size (22 residues) and
charge (+5) and biological properties. P19(5|Acp) instead
behaves more like the bee toxin melittin [2,25,60–62], or thehuman cathelicidin LL-37. Indeed, LL-37, like P19(5|Acp), has
a tendency to structure and aggregate in bulk solution under
certain conditions [58], is quite cytotoxic [15], and its
cytotoxicity and antimicrobial activities are quite medium
sensitive [63]. We have furthermore found that these two
peptides behave similarly in flow cytometric studies on T-
lymphocytes [42].
11. Size
A reasonable potency and spectrum of activity has been
observed with model α-helical AMPs as short as 12 residues
[8,64]. We have reduced the size of P19(9|B) by deleting either
N- or C-terminal positions in the template stepwise (Table 3)
[38]. This resulted in a gradual reduction of activity, especially
towards Gram-positive species, so that it was effectively
Table 3
Sequences of selected model peptides
Peptide Sequence a Molecular Mass (Da)
Calculated Measured b
P19(5) Gly–Nle–Nle–Gln–Gln–Nle–Gly–Orn–Orn–Nle–Orn–Gln–Nle–Nle–Gln–Orn–Nle–Gly–Tyr 2112.6 2113.2
P19(5|B) Gly–Nle–Nle–Gln–Gln–Nle–Aib–Orn–Orn–Aib–Orn–Gln–Aib–Nle–Gln–Orn–Nle–Gly–Tyr 2084.6 2085.2
P19(5|Acp) Gly–Nle–Nle–Gln–Gln–Nle–Acp–Orn–Orn–Acp–Orn–Gln–Acp–Nle–Gln–Orn–Nle–Gly–Tyr 2162.7 2163.2
P19(5|Deg) Gly–Abu–Abu–Gln–Gln–Abu–Deg–Orn–Orn–Deg–Orn–Gln–Deg–Abu–Gln–Orn–Abu–Gly–Tyr 2028.5 2028.0
P19(5|Abu) Gly–Abu–Abu–Gln–Gln–Abu–Aib–Orn–Orn–Aib–Orn–Gln–Aib–Abu–Gln–Orn–Abu–Gly–Tyr 1944.3 1944.4
P19(5|Dpg) Gly–Nva–Nva–Asn–Asn–Nva–Dpg–Orn–Orn–Dpg–Orn–Asn–Dpg–Nva–Asn–Orn–Nva–Gly–Tyr 2126.6 2126.4
P19(6) Gly–Nle–Nle–Gln–Orn–Nle–Gly–Gln–Orn–Nle–Orn–Gln–Nle–Nle–Orn–Orn–Nle–Gly–Tyr 2098.7 2098.6
P19(8) Gly–Nle–Nle–Gln–Orn–Nle–Gly–Orn–Orn–Nle–Orn–Orn–Nle–Gly–Orn–Orn–Nle–Gly–Tyr 2014.6 2014.2
P19(9|B) Gly–Nle–Nle–Orn–Orn–Nle–Aib–Orn–Orn–Aib–Orn–Orn–Aib–Nle–Orn–Orn–Nle–Gly–Tyr 2028.6 2028.1
P19(9|Ala7) Gly–Leu–Leu–Lys–Lys–Ile–Ala–Lys–Lys–Ala–Lya–Lys–Ala–Leu–Lys–Lys–Leu–Gly–Tyr 2098.8 2099.1
P19(9|Gly7) Gly–Leu–Leu–Lys–Lys–Ile–Gly–Lys–Lys–Ala–Lya–Lys–Ala–Leu–Lys–Lys–Leu–Gly–Tyr 2084.7 2084.9
P19(9|Gly7,14) Gly–Leu–Leu–Lys–Lys–Ile–Gly–Lys–Lys–Ala–Lya–Lys–Ala–Gly–Lys–Lys–Leu–Gly–Tyr 2028.6 2028.5
P19(1|E) Gly–Nle–Nle–Gln–Orn–Nle–Gly–Glu–Gln–Nle–Gln–Glu–Nle–Nle–Orn–Gln–Nle–Gly–Tyr 2142.6 2142.5
P13(5|B) Gly–Nle–Aib–Orn–Orn–Nle–Aib–Orn–Orn–Nle–Nle–Gly–Tyr 1373.8 1373.7
Pilosulin P1 Gly–Leu–Gly–Ser–Val–Phe–Gly–Arg–Leu–Ala–Arg–Ile–Leu–Gly–Arg–Val–Ile–Pro–Lys–Val 2107.6 2107.5
Pilosulin P2 Gly–Leu–Leu–Ser–Lys–Phe–Gly–Arg–Leu–Ala–Arg–Lys–Leu–Ala–Arg–Val–Ile–Pro–Lys–Val 2221.8 2221.5
a Abu, 2-aminobutyric acid; Acp, aminocylcopentanecarboxylic acid; Aib, 2-aminoisobutyric acid; Dab, 2,4-diaminobutyric acid; Dap, 2,3-diaminopropionic acid;
Deg, diethylglycine; Dpg, dipropylglycine; Nle, norleucine; Nva, norvaline; Orn, ornithine. All peptides are amidated.
b Mass error ≤0.3 Da.
1446 I. Zelezetsky, A. Tossi / Biochimica et Biophysica Acta 1758 (2006) 1436–1449abolished at 14 residues, even though the shortened peptides
structured adequately and had a sufficient charge. Limiting the
size simply resulted in an insufficient number of large aliphatic
residues for significant interaction to occur with microbial
membranes. Reconstituting the hydrophobic sector by replacing
one or two polar residues and one Aib with Nle in fact resulted
in a dramatic improvement in potency, which became
comparable to that of larger peptides of equivalent charge,
against both bacterial and fungal species. In the design of
shortened peptides, it is thus important to balance a sufficiently
high charge (large polar sector) and adequate helix forming
propensity (e.g. small Aib residues) with the presence of a
sufficient number of large aliphatic residues to ensure an
adequate hydrophobicity sector. It may be significant, in this
respect, that several studies aimed at defining short AMPs made
use of Phe and Trp residues in the hydrophobic sector [65],
although this may increase cytotoxicity.
12. Refining peptide design: rational use of minimal amino
acid substitutions
Our experience with numerous natural peptides
[27,44,66,67], as well as with the rationally designed α-helical
AMPs described above [8,34,35,38,52] has taught us that quite
subtle changes in the peptides' physico-chemical properties can
have a marked effect on biological activity, modulating both
potency, spectrum of activity and selectivity. In a recent study
we have demonstrated that the rational use of minimal amino
acid substitutions can improve the biological properties, and in
particular the selectivity (in terms of a reduced cytotoxicity)
[40].
As the propensity for helical structuring in particular
correlates with cytotoxicity [52], we felt that it could be a key
parameter in tuning selectivity. This could be effected by
introducing residues capable of locally increasing the flexibilityof the helix (e.g. Gly, β-alanine, statine analogues), or
disrupting the helical conformation (e.g. Pro, D-Nle) at key
positions. We had noticed that positions 7 and/or 14 often
presented the small, flexible residue glycine with a significant
frequency (∼30%) in natural peptides [8], and both in vitro and
in vivo toxicity studies on model peptides had indicated that its
presence could in fact affect the cytotoxicity on host cells
[38,52]. We thus prepared a series of peptides with systematic
variation only of residue 7 in the potent but cytotoxic peptide
P19(9|B).
The small, flexible residues Gly or β-Ala did not greatly
reduce the propensity for structuring in the presence of TFE or
SDS, but substantially decreased the cytotoxic activity while
not affecting antimicrobial potency. More marked destructuring,
by introducing proline, somewhat reduced antimicrobial
potency towards some bacteria (e.g. S. aureus), but it
maintained a reasonable activity towards others with excep-
tionally low haemolytic activity. The use of D-Nle to
destructure the peptide, or phenylstatine to increase flexibility,
was instead unsuccessful, as it simultaneously increased
hydrophobicity, leading to increased cytotoxicity.
When P19(9|B) was converted to the closest proteinogenic
analogue, P19(9|Ala7) (Table 3), in view of bioproduction
requirements, a global slight decrease in hydrophobicity
contributed to improve its potency/selectivity balance. Insertion
of Gly at position 7 then improved it further [40]. Curiously,
insertion of Gly at position 14, with or without Gly at position 7,
had a significantly more marked effect on structuring, and while
obtaining a lowered cytotoxicity, also considerably decreased
the antimicrobial potency.
In this study we thus showed that i) modification of the
hydrophobicity and degree of structuring both affected the
balance between antimicrobial potency and cytotoxicity, and
that this applied also to single residue modification; ii) positions
7 and 14 in short α-helical peptides are key sites in determining
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selectivity, while position 14 appears less tolerant.
13. Identification of new peptide sequences in protein
database
Apart from being useful in guiding the design of AMPs for
SAR studies, sequence templates can also be used for
searching databases for new sequences with potential
antimicrobial activity [41]. Our helical template was used to
prepare sequence patterns to scan the Swiss-Prot Database,
using the ScanProsite tool. In this manner, we identified a
segment in pilosulin 1, a 56 residue cytotoxic peptide from the
venom of the jumper ant Myrmecia pilosula, which complied
closely to the template (Table 3). This segment, corresponding
to the 20 N-terminal residues, was synthesized and showed a
potent and broad spectrum antimicrobial activity, including
standard and multi-drug resistant Gram-positive and Gram-
negative bacteria and C. albicans, confirming the validity of
the search method (Table 2). Four amino acid substitutions
were then affected to further increase compliance of the
sequence to the template, and to take into account the design
criteria described above. This yielded a variant with improved
antibacterial and significantly reduced haemolytic activity
(Table 2).
14. Concluding remarks and future directions
The work described in this review is but a small part of the
enormous effort that has been expended by many groups
towards understanding the mode of action of helical antimicro-
bial peptides, and in particular the functional consequences of
their interactions with biological membranes. Our studies
indicate that the physical interaction of α-helical AMPs with
membranes, as proposed by the various mechanisms that can be
included in the carpet model, remains a principal factor leading
to cellular inactivation. This is confirmed by the fact that we
could observe a good correlation between the behaviour of
peptides in simple model systems such as structuring in the
presence of SDS micelles or retention times in the C18 phase,
with bacterial permeabilization and killing activities. In
particular, the rational design of peptides with varying
hydrophobic and polar face depths would seem to indicate
that these peptides need to float with their whole length deeply
inserted into the lipid layer, and that the snorkel effect plays a
significant role in membrane interaction. This applies to both
bacterial and host cells, but in the latter case we could
distinguish distinct mechanisms depending on the conforma-
tional stability of the peptides. This seemed to be a key
parameter in modulating cytotoxicity towards host cells,
together with hydrophobicity, and could be used to tune
selectivity also at the level of single residue variations. The fact
that the membrane appears to be the principal target for our
AMPs does not however exclude that other mechanisms
involving the bacterial cell wall and membrane (such as
activation of autolytic enzymes in bacteria [68], or of
endogenous phospholipases in host cells [69]), or involvinginteractions with internal targets once the membrane is
breached, could have important accessory roles.
Future studies need to take a wider view, better accounting
for this complexity. They should account for interactions with
other components of the cell wall which the peptides may meet
on their way to the membrane, as well as interactions with
proteic components of the membrane itself and cytoplasmic
entities the AMPs may come into contact with on translocating
through it. All these points of interaction reflect in a multimodal
offensive action by the AMPs, which broadens their antimi-
crobial activity spectrum. These studies will thus need to
provide better resolution snapshots of each stage in the
sequence – approach; membrane insertion; docking to mem-
brane-associated targets; intra-membrane assembly and channel
formation; translocation; cytoplasmic target docking. Awinning
strategy may be the combined use of specific biophysical and
biochemical methods. Several spectroscopic techniques can be
used to obtain structural definition of the peptides at different
levels of resolution (NMR, ATR-FTIR, CD, neutron scattering
and atomic force spectroscopy) in the presence of well defined
model systems (isolated cell wall components, liposomes,
LUVs, etc.). Peptide-linked environment probes, surface
plasmon resonance, fluorescent dye release from liposomes
and electrical measurements of membrane conductance and
capacitance, used in model systems, can provide insight into
insertion, assembly and permeabilization events. Flow cyto-
metric methods, confocal and electron microscopies and the use
of membrane integrity and polarization probes can instead all be
used to follow the effect of AMPs on whole cells. The integrated
analysis of the data flow from real and model system will then
need to consider both points of convergence and divergence to
provide a clearer picture of peptides' action sequence.
Much useful information can also come from evolutionary
studies. AMPs are at the interface between the host and its
microbial biota and may thus be subject to positive selection for
variation to cope with changes in environment and living habits.
We have undertaken a systematic study of variations in AMP
families from several closely related primate species, including
man [70]. Most recently we have undertaken a fascinating study
of positively selected variations in homologues of the human
helical peptide LL-37 [42]. We could observe how evolution has
favoured alterations in the charge while little affecting the
overall amphipathic structure, alternatively selecting for the
different action modes we had observed in model peptides, and
possibly predisposing these peptides for different functions in
host defence.
We hope that the considerations presented in this review will
be useful to better understand the behaviour of natural α-helical
antimicrobial peptides and toxins, and furnish a framework for
the design of synthetic AMPs with optimized activity/selectivity
profiles for possible biomedical applications.
Acknowledgements
This work was supported by grants from the Italian Ministry
of Universities and Scientific Research (PRIN 2003), and
from a Friuli-Venezia Giulia regional grant. I. Zelezetsky
1448 I. Zelezetsky, A. Tossi / Biochimica et Biophysica Acta 1758 (2006) 1436–1449acknowledges University of Trieste Consortium for Interna-
tional Development and Central European Initiative research
fellowships.
References
[1] D.F. Sargent, R. Schwyzer, Membrane lipid phase as catalyst for peptide–
receptor interactions, Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 5774–5778.
[2] J.I. Kourie, A.A. Shorthouse, Properties of cytotoxic peptide-formed ion
channels, Am. J. Physiol.: Cell Physiol. 278 (2000) C1063–C1087.
[3] M. Zasloff, Antimicrobial peptides in health and disease, N. Engl. J. Med.
347 (2002) 1199–1200.
[4] A.E. Frankel, D.M. Neville, T.A. Bugge, R.J. Kreitman, S.H. Leppla,
Immunotoxin therapy of hematologic malignancies, Semin. Oncol. 30
(2003) 545–557.
[5] N. Papo, Y. Shai, New lytic peptides based on the D,L-amphipathic helix
motif preferentially kill tumor cells compared to normal cells, Biochem-
istry 42 (2003) 9346–9354.
[6] M. Zasloff, Antimicrobial peptides of multicellular organisms, Nature 415
(2002) 389–395.
[7] Y. Shai, Mode of action of membrane active antimicrobial peptides,
Biopolymers 66 (2002) 236–248.
[8] A. Tossi, L. Sandri, A. Giangaspero, Amphipathic, alpha-helical
antimicrobial peptides, Biopolymers 55 (2000) 4–30.
[9] Z. Oren, Y. Shai, Mode of action of linear amphipathic alpha-helical
antimicrobial peptides, Biopolymers 47 (1998) 451–463.
[10] K. Matsuzaki, Magainins as paradigm for the mode of action of pore
forming polypeptides, Biochim. Biophys. Acta 1376 (1998) 391–400.
[11] R.E. Hancock, D.S. Chapple, Peptide antibiotics, Antimicrob. Agents
Chemother 43 (1999) 1317–1323.
[12] M.M. Juban, M.M. Javadpour, M.D. Barkley, Circular dichroism studies of
secondary structure of peptides, Methods Mol. Biol. 78 (1997) 73–78.
[13] K.A. Henzler Wildman, D.K. Lee, A. Ramamoorthy, Mechanism of lipid
bilayer disruption by the human antimicrobial peptide, LL-37, Biochem-
istry 42 (2003) 6545–6558.
[14] F. Porcelli, B. Buck, D.K. Lee, K.J. Hallock, A. Ramamoorthy, G. Veglia,
Structure and orientation of pardaxin determined by NMR experiments in
model membranes, J. Biol. Chem. 279 (2004) 45815–45823.
[15] Z. Oren, J.C. Lerman, G.H. Gudmundsson, B. Agerberth, Y. Shai,
Structure and organization of the human antimicrobial peptide LL-37 in
phospholipid membranes: relevance to the molecular basis for its non-cell-
selective activity, Biochem. J. 341 (Pt. 3) (1999) 501–513.
[16] A. Mecke, D.K. Lee, A. Ramamoorthy, B.G. Orr, M.M. Banaszak Holl,
Membrane thinning due to antimicrobial peptide binding: an atomic force
microscopy study of MSI-78 in lipid bilayers, Biophys. J. 89 (2005)
4043–4050.
[17] D.A. Steinberg, R.I. Lehrer, Designer assays for antimicrobial peptides.
Disputing the “one-size-fits-all” theory, Methods Mol. Biol. 78 (1997)
169–186.
[18] A. Tossi, M. Scocchi, M. Zanetti, R. Gennaro, P. Storici, D. Romeo, An
approach combining rapid cDNA amplification and chemical synthesis for
the identification of novel, cathelicidin-derived, antimicrobial peptides,
Methods Mol. Biol. 78 (1997) 133–150.
[19] S.J. Ludtke, K. He, Y. Wu, H.W. Huang, Cooperative membrane insertion
of magainin correlated with its cytolytic activity, Biochim. Biophys. Acta
1190 (1994) 181–184.
[20] S. Ludtke, K. He, H. Huang, Membrane thinning caused by magainin 2,
Biochemistry 34 (1995) 16764–16769.
[21] S.J. Ludtke, K. He, W.T. Heller, T.A. Harroun, L. Yang, H.W. Huang,
Membrane pores induced by magainin, Biochemistry 35 (1996)
13723–13728.
[22] K. Matsuzaki, O. Murase, H. Tokuda, S. Funakoshi, N. Fujii, K. Miyajima,
Orientational and aggregational states of magainin 2 in phospholipid
bilayers, Biochemistry 33 (1994) 3342–3349.
[23] K. Matsuzaki, O. Murase, N. Fujii, K. Miyajima, Translocation of a
channel-forming antimicrobial peptide, magainin 2, across lipid bilayers
by forming a pore, Biochemistry 34 (1995) 6521–6526.[24] K. Matsuzaki, O. Murase, N. Fujii, K. Miyajima, An antimicrobial peptide,
magainin 2, induced rapid flip-flop of phospholipids coupled with pore
formation and peptide translocation, Biochemistry 35 (1996) 11361–11368.
[25] N. Papo, Y. Shai, Exploring peptide membrane interaction using surface
plasmon resonance: differentiation between pore formation versus
membrane disruption by lytic peptides, Biochemistry 42 (2003) 458–466.
[26] M. Dathe, H. Nikolenko, J. Meyer, M. Beyermann, M. Bienert,
Optimization of the antimicrobial activity of magainin peptides by
modification of charge, FEBS Lett. 501 (2001) 146–150.
[27] A. Tossi, M. Scocchi, B. Skerlavaj, R. Gennaro, Identification and
characterization of a primary antibacterial domain in CAP18, a
lipopolysaccharide binding protein from rabbit leukocytes, FEBS Lett.
339 (1994) 108–112.
[28] B. Skerlavaj, R. Gennaro, L. Bagella, L. Merluzzi, A. Risso, M. Zanetti,
Biological characterization of two novel cathelicidin-derived peptides and
identification of structural requirements for their antimicrobial and cell
lytic activities, J. Biol. Chem. 271 (1996) 28375–28381.
[29] D. Oh, S.Y. Shin, S. Lee, J.H. Kang, S.D. Kim, P.D. Ryu, K.S. Hahm, Y.
Kim, Role of the hinge region and the tryptophan residue in the synthetic
antimicrobial peptides, cecropin A(1–8)-magainin 2(1–12) and its
analogues, on their antibiotic activities and structures, Biochemistry 39
(2000) 11855–11864.
[30] S.E. Blondelle, E. Takahashi, R.A. Houghten, E. Perez-Paya, Rapid
identification of compounds with enhanced antimicrobial activity by using
conformationally defined combinatorial libraries, Biochem. J. 313 (1)
(1996) 141–147.
[31] S.E. Blondelle, R.A. Houghten, Novel antimicrobial compounds identified
using synthetic combinatorial library technology, Trends Biotechnol. 14
(1996) 60–65.
[32] A. Pini, A. Giuliani, C. Falciani, Y. Runci, C. Ricci, B. Lelli, M. Malossi, P.
Neri, G.M. Rossolini, L. Bracci, Antimicrobial activity of novel
dendrimeric peptides obtained by phage display selection and rational
modification, Antimicrob. Agents Chemother. 49 (2005) 2665–2672.
[33] H.-H. Kristensen, D. Yaver, Antimicrobial peptides, Innov. Pharm.
Technol. (2004) 77–82.
[34] A. Tossi, C. Tarantino, D. Romeo, Design of synthetic antimicrobial
peptides based on sequence analogy and amphipathicity, Eur. J. Biochem.
250 (1997) 549–558.
[35] E. Tiozzo, G. Rocco, A. Tossi, D. Romeo, Wide-spectrum antibiotic
activity of synthetic, amphipathic peptides, Biochem. Biophys. Res.
Commun. 249 (1998) 202–206.
[36] M. Dathe, T. Wieprecht, Structural features of helical antimicrobial
peptides: their potential to modulate activity on model membranes and
biological cells, Biochim. Biophys. Acta 1462 (1999) 71–87.
[37] M.R. Yeaman, N.Y. Yount, Mechanisms of antimicrobial peptide action
and resistance, Pharmacol. Rev. 55 (2003) 27–55.
[38] A. Giangaspero, L. Sandri, A. Tossi, Amphipathic alpha helical
antimicrobial peptides, Eur. J. Biochem. 268 (2001) 5589–5600.
[39] I. Zelezetsky, S. Pacor, U. Pag, N. Papo, Y. Shai, H.G. Sahl, A. Tossi,
Controlled alteration of the shape and conformational stability of alpha-
helical cell-lytic peptides: effect on mode of action and cell specificity,
Biochem. J. 390 (2005) 177–188.
[40] I. Zelezetsky, U. Pag, H.G. Sahl, A. Tossi, Tuning the biological properties
of amphipathic alpha-helical antimicrobial peptides: rational use of
minimal amino acid substitutions, Peptides 26 (2005) 2368–2376.
[41] I. Zelezetsky, U. Pag, N. Antcheva, H.G. Sahl, A. Tossi, Identification and
optimization of an antimicrobial peptide from the ant venom toxin
pilosulin, Arch. Biochem. Biophys. 434 (2005) 358–364.
[42] I. Zelezetsky, A. Pontillo, L. Puzzi, N. Antcheva, L. Segat, S. Pacor, S.
Crovella, A. Tossi, Evolution of the primate cathelicidin— correlation
between structural variations and antimicrobial activity, J. Biol. Chem.
(submitted for publication).
[43] A. Mor, P. Nicolas, The NH2-terminal alpha-helical domain 1–18 of
dermaseptin is responsible for antimicrobial activity, J. Biol. Chem. 269
(1994) 1934–1939.
[44] P. Storici, M. Scocchi, A. Tossi, R. Gennaro, M. Zanetti, Chemical
synthesis and biological activity of a novel antibacterial peptide deduced
from a pig myeloid cDNA, FEBS Lett. 337 (1994) 303–307.
1449I. Zelezetsky, A. Tossi / Biochimica et Biophysica Acta 1758 (2006) 1436–1449[45] A. Tossi, L. Sandri, A. Giangaspero, New consensus hydrophobicity scale
extended to non-proteinogenic amino acids, in: E. Benedetti, C. Pedone
(Eds.), Peptides 2002: Proceedings of the 27th European Peptide
Symposium, Edizioni Ziino, Naples, Italy, 2002, pp. 416–417.
[46] C. Toniolo, M. Crisma, F. Formaggio, C. Peggion, Control of peptide
conformation by the Thorpe-Ingold effect (C alpha-tetrasubstitution),
Biopolymers 60 (2001) 396–419.
[47] M. Dathe, T. Wieprecht, H. Nikolenko, L. Handel, W.L. Maloy, D.L.
MacDonald, M. Beyermann, M. Bienert, Hydrophobicity, hydrophobic
moment and angle subtended by charged residues modulate antibacterial
and haemolytic activity of amphipathic helical peptides, FEBS Lett. 403
(1997) 208–212.
[48] Y. Chen, C.T. Mant, S.W. Farmer, R.E. Hancock, M.L. Vasil, R.S. Hodges,
Rational design of alpha-helical antimicrobial peptides with enhanced
activities and specificity/therapeutic index, J. Biol. Chem. 280 (2005)
12316–12329.
[49] Y. Jin, J. Hammer, M. Pate, Y. Zhang, F. Zhu, E. Zmuda, J. Blazyk,
Antimicrobial activities and structures of two linear cationic peptide
families with various amphipathic beta-sheet and alpha-helical potentials,
Antimicrob. Agents Chemother. 49 (2005) 4957–4964.
[50] E. Krause, M. Beyermann, M. Dathe, S. Rothemund, M. Bienert, Location
of an amphipathic alpha-helix in peptides using reversed-phase HPLC
retention behavior of D-amino acid analogs, Anal. Chem. 67 (1995)
252–258.
[51] Z. Oren, J. Ramesh, D. Avrahami, N. Suryaprakash, Y. Shai, R. Jelinek,
Structures and mode of membrane interaction of a short alpha helical lytic
peptide and its diastereomer determined by NMR, FTIR, and fluorescence
spectroscopy, Eur. J. Biochem. 269 (2002) 3869–3880.
[52] S. Pacor, A. Giangaspero, M. Bacac, G. Sava, A. Tossi, Analysis of the
cytotoxicity of synthetic antimicrobial peptides on mouse leucocytes:
implications for systemic use, J. Antimicrob. Chemother. 50 (2002)
339–348.
[53] M. Monne, I. Nilsson, M. Johansson, N. Elmhed, G. von Heijne, Positively
and negatively charged residues have different effects on the position in the
membrane of a model transmembrane helix, J. Mol. Biol. 284 (1998)
1177–1183.
[54] T. Wieprecht, M. Dathe, R.M. Epand, M. Beyermann, E. Krause, W.L.
Maloy, D.L. MacDonald, M. Bienert, Influence of the angle subtended by
the positively charged helix face on the membrane activity of amphipathic,
antibacterial peptides, Biochemistry 36 (1997) 12869–12880.
[55] M. Dathe, J. Meyer, M. Beyermann, B. Maul, C. Hoischen, M. Bienert,
General aspects of peptide selectivity towards lipid bilayers and cell
membranes studied by variation of the structural parameters of amphipathic
helical model peptides, Biochim. Biophys. Acta 1558 (2002) 171–186.
[56] S.E. Blondelle, J.M. Ostresh, R.A. Houghten, E. Perez-Paya, Induced
conformational states of amphipathic peptides in aqueous/lipid environ-
ments, Biophys. J. 68 (1995) 351–359.[57] M.E. Houston Jr., L.H. Kondejewski, D.N. Karunaratne, M. Gough, S.
Fidai, R.S. Hodges, R.E. Hancock, Influence of preformed alpha–helix
and alpha–helix induction on the activity of cationic antimicrobial
peptides, J. Pept. Res. 52 (1998) 81–88.
[58] J. Johansson, G.H. Gudmundsson, M.E. Rottenberg, K.D. Berndt, B.
Agerberth, Conformation-dependent antibacterial activity of the natu-
rally occurring human peptide LL-37, J. Biol. Chem. 273 (1998)
3718–3724.
[59] K. Matsuzaki, K. Sugishita, K. Miyajima, Interactions of an antimicrobial
peptide, magainin 2, with lipopolysaccharide-containing liposomes as a
model for outer membranes of gram-negative bacteria, FEBS Lett. 449
(1999) 221–224.
[60] L. Yang, T.A. Harroun, T.M. Weiss, L. Ding, H.W. Huang, Barrel-stave
model or toroidal model? A case study on melittin pores, Biophys. J. 81
(2001) 1475–1485.
[61] L. Ding, L. Yang, T.M. Weiss, A.J. Waring, R.I. Lehrer, H.W. Huang,
Interaction of antimicrobial peptides with lipopolysaccharides, Biochem-
istry 42 (2003) 12251–12259.
[62] K. Matsuzaki, S. Yoneyama, K. Miyajima, Pore formation and
translocation of melittin, Biophys. J. 73 (1997) 831–838.
[63] J. Turner, Y. Cho, N.N. Dinh, A.J. Waring, R.I. Lehrer, Activities of LL-37,
a cathelin-associated antimicrobial peptide of human neutrophils, Anti-
microb. Agents Chemother. 42 (1998) 2206–2214.
[64] S.E. Blondelle, R.A. Houghten, Design of model amphipathic peptides
having potent antimicrobial activities, Biochemistry 31 (1992)
12688–12694.
[65] R. Bessalle, A. Gorea, I. Shalit, J.W. Metzger, C. Dass, D.M. Desiderio, M.
Fridkin, Structure–function studies of amphiphilic antibacterial peptides, J.
Med. Chem. 36 (1993) 1203–1209.
[66] M. Boniotto, N. Antcheva, I. Zelezetsky, A. Tossi, V. Palumbo, M.V. Verga
Falzacappa, S. Sgubin, L. Braida, A. Amoroso, S. Crovella, A study of
host defence peptide beta-defensin 3 in primates, Biochem. J. 374 (2003)
707–714.
[67] N. Antcheva, M. Boniotto, I. Zelezetsky, S. Pacor, M.V. Falzacappa, S.
Crovella, A. Tossi, Effects of positively selected sequence variations in
human and Macaca fascicularis beta-defensins 2 on antimicrobial activity,
Antimicrob. Agents Chemother. 48 (2004) 685–688.
[68] I. Ginsburg, Bactericidal cationic peptides can also function as
bacteriolysis-inducing agents mimicking beta-lactam antibiotics?; it is
enigmatic why this concept is consistently disregarded, Med. Hypotheses
62 (2004) 367–374.
[69] S.S. Saini, A.K. Chopra, J.W. Peterson, Melittin activates endogenous
phospholipase D during cytolysis of human monocytic leukemia cells,
Toxicon 37 (1999) 1605–1619.
[70] S. Crovella, N. Antcheva, I. Zelezetsky, M. Boniotto, S. Pacor, M.V. Verga
Falzacappa, A. Tossi, Primate beta-defensins — structure, function and
evolution, Curr. Protein Pept. Sci. 6 (2005) 7–21.
